Current and historical daily PE Ratio for CanSino Biologics Inc (
SHSE:688185
) from 2020 to May 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. CanSino Biologics stock (SHSE:688185) PE ratio as of May 10 2024 is 0.
More Details
CanSino Biologics Inc (SHSE:688185) PE Ratio (TTM) Chart
CanSino Biologics Inc (SHSE:688185) PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Total 905
- 1
- 2
- 3
- 4
- 5
- 6
- 11
| CanSino Biologics PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-10 | At Loss | 2024-03-01 | At Loss |
| 2024-05-09 | At Loss | 2024-02-29 | At Loss |
| 2024-05-08 | At Loss | 2024-02-28 | At Loss |
| 2024-05-07 | At Loss | 2024-02-27 | At Loss |
| 2024-05-06 | At Loss | 2024-02-26 | At Loss |
| 2024-04-30 | At Loss | 2024-02-23 | At Loss |
| 2024-04-29 | At Loss | 2024-02-22 | At Loss |
| 2024-04-26 | At Loss | 2024-02-21 | At Loss |
| 2024-04-25 | At Loss | 2024-02-20 | At Loss |
| 2024-04-24 | At Loss | 2024-02-19 | At Loss |
| 2024-04-23 | At Loss | 2024-02-08 | At Loss |
| 2024-04-22 | At Loss | 2024-02-07 | At Loss |
| 2024-04-19 | At Loss | 2024-02-06 | At Loss |
| 2024-04-18 | At Loss | 2024-02-05 | At Loss |
| 2024-04-17 | At Loss | 2024-02-02 | At Loss |
| 2024-04-16 | At Loss | 2024-02-01 | At Loss |
| 2024-04-15 | At Loss | 2024-01-31 | At Loss |
| 2024-04-12 | At Loss | 2024-01-30 | At Loss |
| 2024-04-11 | At Loss | 2024-01-29 | At Loss |
| 2024-04-10 | At Loss | 2024-01-26 | At Loss |
| 2024-04-09 | At Loss | 2024-01-25 | At Loss |
| 2024-04-08 | At Loss | 2024-01-24 | At Loss |
| 2024-04-03 | At Loss | 2024-01-23 | At Loss |
| 2024-04-02 | At Loss | 2024-01-22 | At Loss |
| 2024-04-01 | At Loss | 2024-01-19 | At Loss |
| 2024-03-29 | At Loss | 2024-01-18 | At Loss |
| 2024-03-28 | At Loss | 2024-01-17 | At Loss |
| 2024-03-27 | At Loss | 2024-01-16 | At Loss |
| 2024-03-26 | At Loss | 2024-01-15 | At Loss |
| 2024-03-25 | At Loss | 2024-01-12 | At Loss |
| 2024-03-22 | At Loss | 2024-01-11 | At Loss |
| 2024-03-21 | At Loss | 2024-01-10 | At Loss |
| 2024-03-20 | At Loss | 2024-01-09 | At Loss |
| 2024-03-19 | At Loss | 2024-01-08 | At Loss |
| 2024-03-18 | At Loss | 2024-01-05 | At Loss |
| 2024-03-15 | At Loss | 2024-01-04 | At Loss |
| 2024-03-14 | At Loss | 2024-01-03 | At Loss |
| 2024-03-13 | At Loss | 2024-01-02 | At Loss |
| 2024-03-12 | At Loss | 2023-12-29 | At Loss |
| 2024-03-11 | At Loss | 2023-12-28 | At Loss |
| 2024-03-08 | At Loss | 2023-12-27 | At Loss |
| 2024-03-07 | At Loss | 2023-12-26 | At Loss |
| 2024-03-06 | At Loss | 2023-12-25 | At Loss |
| 2024-03-05 | At Loss | 2023-12-22 | At Loss |
| 2024-03-04 | At Loss | 2023-12-21 | At Loss |
CanSino Biologics Inc (SHSE:688185) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
CanSino Biologics Inc
ISIN : CNE100004BM0
Share Class Description:
SHSE:688185: Class ACompare
Compare
Traded in other countries / regions
688185.China06185.Hong KongCJH.GermanyCASBF.USA IPO Date
2020-08-13Description
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers